Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome
- PMID: 15657466
- DOI: 10.1164/rccm.200407-857OC
Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome
Abstract
Rationale: There is currently no optimal treatment or effective drug for severe acute respiratory syndrome (SARS), because the immunopathologic mechanism is poorly understood.
Objectives: To explore the immune mechanism underlying the pathogenesis of SARS, we studied the expression profile of cytokines/chemokines in the blood and the immunopathology of the lung and lymphoid tissues.
Methods: Fourteen cytokines/chemokines in the blood of 23 patients with SARS were dynamically screened, using a bead-based multiassay system. Reverse transcription-polymerase chain reaction was performed to amplify mRNA. Histopathology of the lung and lymphoid tissues at autopsy was examined, using methods of immunohistochemistry and double immunofluorescence staining.
Main results: Interferon-inducible protein-10 (IP-10) was markedly elevated in the blood during the early stage of SARS, and remained at a high level until convalescence. Moreover, IP-10 was highly expressed in both lung and lymphoid tissues, where monocyte-macrophage infiltration and depletion of lymphocytes were observed. The levels of interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 were concomitantly increased in the blood of the patients with superinfection, and the mRNAs for these cytokines were also increased in lung tissues.
Conclusions: Induction of IP-10 is a critical event in the initiation of immune-mediated acute lung injury and lymphocyte apoptosis during the development of SARS. Superinfection after the immune injury is the main cause of death. The prompt elevation of interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 is a sign of superinfection, indicating a high risk of death.
Similar articles
-
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.J Transl Autoimmun. 2021;4:100083. doi: 10.1016/j.jtauto.2021.100083. Epub 2021 Jan 6. J Transl Autoimmun. 2021. PMID: 33521616 Free PMC article. Review.
-
Studies of severe acute respiratory syndrome coronavirus pathology in human cases and animal models.Vet Pathol. 2010 Sep;47(5):881-92. doi: 10.1177/0300985810378760. Epub 2010 Jul 27. Vet Pathol. 2010. PMID: 20664013 Review.
-
Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome.Respirology. 2006 Nov;11(6):715-22. doi: 10.1111/j.1440-1843.2006.00942.x. Respirology. 2006. PMID: 17052299 Free PMC article.
-
Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro.J Virol. 2006 Mar;80(6):2684-93. doi: 10.1128/JVI.80.6.2684-2693.2006. J Virol. 2006. PMID: 16501078 Free PMC article.
-
Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome.Clin Chem. 2005 Dec;51(12):2333-40. doi: 10.1373/clinchem.2005.054460. Epub 2005 Sep 29. Clin Chem. 2005. PMID: 16195357 Free PMC article.
Cited by
-
Cytokine storm and translating IL-6 biology into effective treatments for COVID-19.Front Med. 2023 Dec;17(6):1080-1095. doi: 10.1007/s11684-023-1044-4. Epub 2023 Dec 29. Front Med. 2023. PMID: 38157195 Review.
-
Sustained induction of IP-10 by MRP8/14 via the IFNβ-IRF7 axis in macrophages exaggerates lung injury in endotoxemic mice.Burns Trauma. 2023 Sep 11;11:tkad006. doi: 10.1093/burnst/tkad006. eCollection 2023. Burns Trauma. 2023. PMID: 37701855 Free PMC article.
-
Role of toll-like receptors and nod-like receptors in acute lung infection.Front Immunol. 2023 Aug 16;14:1249098. doi: 10.3389/fimmu.2023.1249098. eCollection 2023. Front Immunol. 2023. PMID: 37662905 Free PMC article. Review.
-
Chemokine Levels among Patients with Middle East Respiratory Syndrome Coronavirus Infection.Vaccines (Basel). 2023 May 31;11(6):1048. doi: 10.3390/vaccines11061048. Vaccines (Basel). 2023. PMID: 37376437 Free PMC article.
-
Associations of the neutrophil/lymphocyte ratio, monocyte/ lymphocyte ratio, and platelet/lymphocyte ratio with COVID-19 disease severity in patients with neurological symptoms: A cross-sectional monocentric study.J Neurosci Rural Pract. 2023 Apr-Jun;14(2):224-229. doi: 10.25259/JNRP_6_2022. Epub 2022 Oct 22. J Neurosci Rural Pract. 2023. PMID: 37181197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous